(Q43748761)

26 November 2017

Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women (English)

1 reference

26 November 2017

1 reference

1 reference

coronary artery disease

1 reference

1

1 reference

26 November 2017

Raul Cavalcante Maranhão

3

1 reference

26 November 2017

Mansur AP

2

1 reference

26 November 2017

Martinez TR

4

1 reference

26 November 2017

Aldrighi JM

5

1 reference

26 November 2017

Ramires JA

6

1 reference

26 November 2017

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

39

1 reference

26 November 2017

3

1 reference

26 November 2017

203-208

1 reference

Relative influence of age and menopause on total and regional body composition changes in postmenopausal women

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Influence of age and menopause on serum lipids and lipoproteins in healthy women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Comparison of a new immunoturbidometric assay of human serum lipoprotein (a) to the ELISA and the IRMA methods

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Immunoturbidimetric determination of lipoprotein(a): improvement in the measurement of turbid and triglyceride-rich samples.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

A potential basis for the thrombotic risks associated with lipoprotein(a).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Lack of increased coronary atherosclerotic risk due to elevated lipoprotein(a) in women > or = 55 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

The significance of high levels of lipoprotein (a) compared with established risk factors in premature coronary artery disease: differences between men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Close relation between lipoprotein (a) levels and atherothrombotic disease in Japanese subjects > 75 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Regression Growth Evaluation Statin Study (RE

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Automated measurement of lipoprotein(a) by immunoturbidimetric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900223-7

7 January 2021

10.1016/S0378-5122(01)00223-7

Identifiers

DOI

1 reference

26 November 2017

1 reference